1 December 2023
Freshfields Advises Novartis on Its Exclusive License Agreement with Legend Biotech
Healthcare & Life Sciences Announced
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Adam Golden Lead | Freshfields | Partner | Not stated | Not stated |
| Jan Rybnicek | Freshfields | Partner | Not stated | Not stated |
| Charles Ramsey | Freshfields | Counsel | Not stated | Not stated |
| Sora Park | Freshfields | Associate | Not stated | Not stated |
| Dylan O'Connor | Freshfields | Associate | Not stated | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 100m ($100 million upfront payment)
- What the figure measures
- Not stated
- Client
- NovartisBuy-side
- Counterparties
- Legend Biotech (Sell-side)